Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2015 Dec 21;66:1–10. doi: 10.1016/j.psyneuen.2015.12.017

Table 4.

Cardiac autonomic measures derived from frequency domain analysis of heart rate variability recorded during undisturbed REM and NREM sleep on a baseline and anticipatory stress night in perimenopausal women with (N=22) and without (N=18) a diagnosis of insomnia.

Group Baseline night
Mean (SD)
Stress night
Mean (SD)
Significant ANOVA
effects

NREM REM NREM REM
HR (bpm) Control 61.2 (5.3) 63.7 (6.6) 63.0 (634) 65.3 (6.0) Night** and
Sleep stage***
Insomnia 63.1 (6.4) 65.9 (5.9) 64.7 (6.7) 67.5 (6.8)

TP (ms2) Control 383.4 (218.2) 368.6 (350.7) 381.0 (289.0) 370.7 (371.2) Night* and
Sleep stage**
Insomnia 337.0 (355.3) 271.6 (335.2) 287.2 (254.6) 200.2 (185.4)

HFa (ms2) Control 80.8 (63.7) 38.2 (45.8) 77.1 (62.2) 37.9 (32.1) Sleep stage ***
Insomnia 72.1 (82.2) 27.0 (36.4) 64.6 (56.4) 18.4 (13.7)

HFnp Control 0.22 (0.09) 0.11 (0.06) 0.22 (0.09) 0.11 (0.06) Sleep stage ***
Insomnia 0.23 (0.07) 0.11 (0.04) 0.24 (0.08) 0.10 (0.05)

HFpf (Hz) Control 0.24 (0.04) 0.25 (0.04) 0.25 (0.04) 0.25 (0.04)
Insomnia 0.25 (0.03) 0.25 (0.04) 0.25 (0.03) 0.25 (0.04)
*

, p<0.05;

**

, p<0.01;

***

, p<0.001. HR, heart rate; TP, total power; HF, high frequency (a= absolute integrated power; pf=peak frequency; np=narrow proportion calculated as the proportion of the absolute high frequency integrated power on the total power);

, analyses based on log-transformed data.